A dilute result means the urine specimen had lower than normal creatinine and specific gravity readings, which can happen from drinking a lot of fluids or, in some cases, from an attempt to beat the test. Under 49 CFR 40.197, what an employer can do next depends on whether the result was negative or positive and, for negative results, exactly how dilute the specimen was. In many cases the employer must send the employee back for an immediate, directly observed recollection, while in others the employer has a choice or no further action is allowed at all.
What "Dilute" Actually Means Under DOT Rules
A dilute reading is not a guess by the lab. It is a defined chemical range. Under 49 CFR 40.88, a laboratory must consider a urine specimen dilute when the creatinine concentration is greater than or equal to 2 mg/dL but less than 20 mg/dL, and the specific gravity is greater than 1.0010 but less than 1.0030, measured on a single aliquot.
That range matters because it separates a normal, if watered down, specimen from one that is so diluted it no longer looks like human urine at all. The same regulation defines a substituted specimen as one where creatinine is less than 2 mg/dL and specific gravity is less than or equal to 1.0010 or greater than or equal to 1.0200, confirmed on both the initial and confirmatory creatinine tests and both the initial and confirmatory specific gravity tests, on two separate aliquots. A substituted result is treated very differently than a dilute one. It is generally handled as a refusal to test, not as a dilution issue, because the chemistry indicates the sample likely was not human urine at all.
Why the Distinction Matters for Employers
Because dilute and substituted trigger different response paths under Part 40, an employer's first job when a lab or medical review officer (MRO) flags a specimen is to confirm which category applies. The MRO will state the finding on the verification report, and the employer's obligations under 40.197 hinge entirely on that classification plus, for negative-dilute cases, the exact creatinine number reported.
Negative-Dilute vs Positive-Dilute: Two Very Different Outcomes
The single biggest source of confusion for employers is treating every dilute result the same way. The rule draws a hard line between a dilute specimen that also tested positive for a prohibited drug and a dilute specimen that tested negative.
Positive-Dilute Specimens
If the drug test itself came back positive and the specimen also happened to be dilute, the dilution does not soften the outcome. Per 40.197(a), the employer must simply treat the test as a verified positive test and must not direct the employee to take another test based on the fact that the specimen was dilute. In other words, dilution offers no path to a retest or a second chance when the underlying result is positive.
Negative-Dilute Specimens
When the test is negative but dilute, the employer's required response depends on the creatinine reading:
- If creatinine is at least 2 mg/dL but no more than 5 mg/dL, the employer must direct the employee to an immediate recollection under direct observation, per 40.197(b)(1).
- If creatinine is above 5 mg/dL, the employer may, but is not required to, direct the employee to take another test immediately, per 40.197(b)(2).
That second option is genuinely optional. Nothing in the rule forces an employer to retest a negative-dilute result once creatinine clears the 5 mg/dL mark, and many employers choose not to, since the person already produced a negative result.
When a Retest Is Allowed and the One-Retest Rule
Part 40 does not allow open-ended retesting just because a result keeps coming back dilute. If a directed recollection is performed and the second specimen is also reported negative-dilute, the employer's authority to keep testing generally ends there. The regulation is explicit that an employer is not permitted to require an additional test simply because the result was dilute again, unless that second result itself falls in the 2 to 5 mg/dL creatinine range, in which case the direct-observation recollection requirement under 40.197(b)(1) applies again.
In practice, this means a negative-dilute finding can trigger at most one mandatory recollection cycle tied to dilution alone. It is not a mechanism for repeated testing of the same employee, and treating it that way can create the kind of documentation and consistency problems that come up in disputes. That is one more reason a defensible chain of custody matters at every step, since the paperwork on collection, dilution ranges, and retest decisions is exactly what gets scrutinized if a result is ever challenged.
Non-DOT Workplace Policy Recommendations
Everything above is written for DOT-regulated safety-sensitive testing. If your company is not DOT regulated, Part 40 does not apply to you directly, but it is still the most tested and litigated framework available, and many non-DOT employers borrow its structure because it holds up.
A few practical steps for non-DOT programs:
- Write the dilute policy down before you need it. Decide in advance how your company will treat a negative-dilute result and put it in your drug-free workplace policy. Deciding case by case after the fact invites inconsistency and claims of unfair treatment.
- Apply the policy the same way across similar situations. Federal guidance for regulated programs allows different policies for different test reasons, for example treating pre-employment testing differently than random testing, but requires that employees be told about the policy in advance and that it be applied consistently within each category. That same discipline serves non-DOT programs well.
- Do not treat a negative-dilute result as a positive. A dilute specimen that tested negative for drugs is a negative test. It is not evidence of drug use, and disciplining an employee as if it were a positive result invites legal exposure.
- Document hydration instructions given at collection. If your collection site tells employees to avoid excessive fluids before a test, keep a record of that instruction. It shows good faith and reduces argument later.
Employers building or refreshing a testing program from scratch, including one covering multiple sites or a large workforce, often find it more practical to standardize supplies and training first. Ordering consistent, quality test cups through a program built to drug test in bulk keeps every collection site working from the same equipment and the same validity checks, which cuts down on the kind of inconsistent dilute readings that create policy headaches in the first place.
How Specimen Validity Features Help Catch Dilution at Collection
The best way to deal with a dilute result is to catch the conditions that cause it before the specimen ever leaves the collection site. Quality test cups with built-in specimen validity testing include a temperature strip and adulterant panels that flag out-of-range specimens on the spot, at the moment of collection, rather than days later when a lab report comes back.
A cup with integrated validity testing typically checks specimen temperature immediately (since a specimen outside the expected temperature window is itself a Part 40 flag), along with pH and creatinine indicators that can suggest heavy water loading before the sample is ever sent out. Building that check into the collection procedure, using drug testing cups designed for validity screening, gives collectors a chance to have an honest conversation with the donor or document an irregularity right away, instead of discovering the problem only after a lab turnaround and an MRO call.
For employers running high volume programs, that early catch also reduces how often the negative-dilute recollection process in 40.197 gets triggered at all, since fewer diluted specimens make it to the lab in the first place. That saves time, reduces the number of directly observed recollections staff have to coordinate, and keeps the testing program moving without sacrificing accuracy.
Frequently asked questions
Does a dilute drug test result mean the employee used drugs?
No. Dilute only describes the water content of the specimen, measured by creatinine and specific gravity under 49 CFR 40.88. A negative-dilute result is still a negative test for drugs. It is not evidence of drug use and should not be treated as one.
Can an employer fire someone for a dilute drug test?
A negative-dilute result by itself is a negative test, so it does not provide grounds for discipline the way a positive result would. If the specimen is dilute and positive, 40.197(a) requires the employer to treat it as a verified positive, and normal company policy for a positive result would apply.
How many times can an employee be retested for a dilute result?
Under 40.197, a negative-dilute result with creatinine between 2 and 5 mg/dL requires one immediate, directly observed recollection. If that recollection also comes back negative-dilute, the employer generally cannot require further retesting based on dilution alone, unless the second result again falls in the 2 to 5 mg/dL range, which triggers the direct observation requirement once more.
What creatinine and specific gravity levels count as dilute?
Per 49 CFR 40.88, a specimen is dilute when creatinine is greater than or equal to 2 mg/dL but less than 20 mg/dL and specific gravity is greater than 1.0010 but less than 1.0030 on a single aliquot. Levels below 2 mg/dL creatinine combined with specific gravity at or below 1.0010 or at or above 1.0200, confirmed on two separate aliquots, indicate a substituted specimen instead, which is handled differently than a simple dilution.
Related reading
Author: American Screening Corp Editorial Team
